89 related articles for article (PubMed ID: 9166453)
41. Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.
Saunders M; Dische S
Br J Cancer Suppl; 1996 Jul; 27():S271-8. PubMed ID: 8763896
[TBL] [Abstract][Full Text] [Related]
42. Modulation of tumor oxygenation and radiosensitivity by a perfluorooctylbromide emulsion.
Rockwell S; Kelley M; Irvin CG; Hughes CS; Porter E; Yabuki H; Fischer JJ
Radiother Oncol; 1991 Oct; 22(2):92-8. PubMed ID: 1957007
[TBL] [Abstract][Full Text] [Related]
43. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland.
Stone HB; Brown JM; Phillips TL; Sutherland RM
Radiat Res; 1993 Dec; 136(3):422-34. PubMed ID: 8278585
[TBL] [Abstract][Full Text] [Related]
44. [Analysis of PO2 in brain tumor and effectiveness of PFC (perfluorochemicals) to increase intratumoral PO2, blood flow and its clinical use].
Kayama T; Sakurai Y; Yoshimoto T
Gan No Rinsho; 1989 Oct; 35(13):1548-53. PubMed ID: 2685395
[TBL] [Abstract][Full Text] [Related]
45. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review.
Horsman MR
Acta Oncol; 1995; 34(5):571-87. PubMed ID: 7546822
[TBL] [Abstract][Full Text] [Related]
46. Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies.
Bache M; Kappler M; Said HM; Staab A; Vordermark D
Curr Med Chem; 2008; 15(4):322-38. PubMed ID: 18288988
[TBL] [Abstract][Full Text] [Related]
47. Oxygen and cancer.
Dunn T
N C Med J; 1997; 58(2):140-3. PubMed ID: 9088144
[TBL] [Abstract][Full Text] [Related]
48. Problems and trends in radiotherapeutic treatment of deep-seated tumors.
Wideröe R
Radiol Clin (Basel); 1975; 44(2):112-41. PubMed ID: 806092
[TBL] [Abstract][Full Text] [Related]
49. Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment.
Graham K; Unger E
Int J Nanomedicine; 2018; 13():6049-6058. PubMed ID: 30323592
[TBL] [Abstract][Full Text] [Related]
50. Magnetic resonance imaging techniques for monitoring changes in tumor oxygenation and blood flow.
Robinson SP; Howe FA; Rodrigues LM; Stubbs M; Griffiths JR
Semin Radiat Oncol; 1998 Jul; 8(3):197-207. PubMed ID: 9634496
[TBL] [Abstract][Full Text] [Related]
51. Impact of tumor hypoxia and anemia on radiation therapy outcomes.
Harrison LB; Chadha M; Hill RJ; Hu K; Shasha D
Oncologist; 2002; 7(6):492-508. PubMed ID: 12490737
[TBL] [Abstract][Full Text] [Related]
52. Perfluorochemicals and hyperbaric oxygen in radiation therapy.
Fischer JJ; Rockwell S; Martin DF
Int J Radiat Oncol Biol Phys; 1986 Jan; 12(1):95-102. PubMed ID: 3511016
[TBL] [Abstract][Full Text] [Related]
53. Manipulation of tumor oxygenation and radiosensitivity through modification of cell respiration. A critical review of approaches and imaging biomarkers for therapeutic guidance.
Gallez B; Neveu MA; Danhier P; Jordan BF
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):700-711. PubMed ID: 28088332
[TBL] [Abstract][Full Text] [Related]
54. Hypoxic tumors and their effect on immune cells and cancer therapy.
Yotnda P; Wu D; Swanson AM
Methods Mol Biol; 2010; 651():1-29. PubMed ID: 20686957
[TBL] [Abstract][Full Text] [Related]
55. The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.
Brown JM
Cancer Res; 1999 Dec; 59(23):5863-70. PubMed ID: 10606224
[TBL] [Abstract][Full Text] [Related]
56. Hypoxia and drug resistance.
Teicher BA
Cancer Metastasis Rev; 1994 Jun; 13(2):139-68. PubMed ID: 7923547
[TBL] [Abstract][Full Text] [Related]
57. Radiosensitization with normobaric oxygen and carbogen.
Rojas A
Radiother Oncol; 1991; 20 Suppl 1():65-70. PubMed ID: 1902320
[No Abstract] [Full Text] [Related]
58. Perfluorochemical emulsions as adjuncts to radiotherapy.
Rockwell S
Biomater Artif Cells Artif Organs; 1988; 16(1-3):519-31. PubMed ID: 3052649
[No Abstract] [Full Text] [Related]
59. Importance of hypoxia in the biology and treatment of brain tumors.
Knisely JP; Rockwell S
Neuroimaging Clin N Am; 2002 Nov; 12(4):525-36. PubMed ID: 12687909
[TBL] [Abstract][Full Text] [Related]
60. Modulating tumor hypoxia by nanomedicine for effective cancer therapy.
Jahanban-Esfahlan R; de la Guardia M; Ahmadi D; Yousefi B
J Cell Physiol; 2018 Mar; 233(3):2019-2031. PubMed ID: 28198007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
